The Wake Forest Institute for Regenerative Medicine (WFIRM) is thrilled to announce the successful renewal of its Research Experiences for Undergraduates (REU) Site grant from the National Science Foundation (NSF).
Novartis is flashing warning signs about the fate of its newly acquired myelofibrosis drug
CHICAGO — Something is off about the way Novartis is talking about pelabresib, its newly acquired and costly treatment for myelofibrosis. I suspect the Swiss